INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES
-
Is Your Legacy EDC Limiting AI's Impact On Your Clinical Data?
AI can enhance clinical data workflows, but aging EDC systems hold teams back. This piece breaks down key barriers and shows what’s needed to modernize data foundations for meaningful AI adoption.
-
Predictions For 2026 In Life Sciences
Experts predict 2026 trends: more pragmatic trial design, expanded use of data and AI for patient matching, and registration and reporting of results for all human trials.
-
Sikich Success For Life Sciences
Explore an innovative solution for early-stage Life Sciences Organizations featuring dimensional charts of accounts, program and project management, multi-subsidiary support, and mass securities.
-
The EMR Interoperability Dream Vs. Clinical Research Reality
Seamless Electronic Medical Record access promises accelerated trials and regulatory-grade evidence, but incomplete, unstructured data requires hybrid strategies using AI and human oversight to bridge gaps.
-
Unlocking The Promise of Digital Health Technologies In Clinical Trials3/23/2026
Discover the scientific, regulatory, and operational hurdles slowing digital health in clinical trials — and how design, guidance, and validation improvements are moving adoption ahead.
-
Strong Bookings And The Disruption Gap Nobody Is Talking About5/6/2026
Understand the real impact of AI on CRO valuations and clinical trial stability. Explore why market data contradicts the "disruption" narrative and what it means for the future of the industry.
-
Medical Monitoring Oversight And Real-Time Data In Clinical Trials5/8/2026
Explore how real-time access to safety data is changing medical monitoring, with insights into continuous analysis, remote data visibility, and what these shifts mean for protecting patients.
-
A Framework For Selecting Reliable Clinical Endpoints From Real-World DHT Data2/25/2025
Dr. Andy Liu presents a case study determining which digital measure of physical activity would be a well-defined and reliable clinical endpoint in a trial including patients with diabetes.
-
Effect Of Etrasimod On Immune Cell Subsets In Colonic Tissue9/25/2025
Etrasimod selectively modulates S1P receptors to reduce inflammation and immune cell trafficking to the gut, showing promise in treating moderate to severe ulcerative colitis.
CLINICAL TRIAL TECHNOLOGY SOLUTIONS
-
See how AI- and automation-powered experiences are replacing manual, disconnected systems to improve patient engagement, enhance data quality, and optimize study design.
-
The Medidata DCT Program is a unique, innovative, and powerful technology solution to virtualize your entire clinical trial, including patient participation, data monitoring and oversight activities, and patient drug dispensation and supply management.
-
TruTechnologies: Clinical Trial Execution, Live
TruTechnologies (Tru) is the industry’s first clinical trial execution system, delivering truly real-time visibility into trial execution at the point of care.
And it’s about time.
-
Ergomed’s Risk-Based Clinical Monitoring and Source Data Verification Approach for Data Integrity
Ergomed ensures the highest data integrity and patient safety standards through our risk-based clinical monitoring and Source Data Verification (SDV) practices. SDV is a critical process in clinical trials that ensures the data collected are accurate, complete, and verifiable against the source documents. We compare data entered into case report forms or electronic data capture systems with the source data to confirm their accuracy and reliability.
-
With the right IRT platform, you can handle inherent complexities and constant change, enabling confident decisions to move life-changing studies forward.